Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mylan NV (NASDAQ:MYL)

42.30
Delayed Data
As of 4:15pm ET
 +0.25 / +0.59%
Today’s Change
33.60
Today|||52-Week Range
50.40
+10.88%
Year-to-Date

Today’s Trading

Previous close42.05
Today’s open42.46
Day’s range42.07 - 42.70
Volume7,442,762
Average volume (3 months)5,765,510
Market cap$22.5B
Dividend yield--
Data as of 4:15pm ET, 02/21/2017

Growth & Valuation

Earnings growth (last year)-27.35%
Earnings growth (this year)+10.09%
Earnings growth (next 5 years)+7.25%
Revenue growth (last year)+21.91%
P/E ratio18.2
Price/Sales2.84
Price/Book2.12

Competitors

 Today’s
change
Today’s
% change
INCYIncyte Corp+1.87+1.55%
VRTXVertex Pharmaceutica...-1.78-2.02%
ZTSZoetis Inc+0.96+1.83%
BAXBaxter International...+0.23+0.46%
Data as of 4:00pm ET, 02/21/2017

Financials

Next reporting dateMarch 1, 2017
EPS forecast (this quarter)$1.42
Annual revenue (last year)$9.5B
Annual profit (last year)$847.6M
Net profit margin8.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts


Search for Jobs